radioimmunotherapy

radioimmunotherapy

radioimmunotherapy n.

“focus on…” session: radioimmunotherapy

Radioimmunotherapy for lymphoma

Radioimmunotherapy strategies for non-Hodgkin's lymphomas

Radioimmunotherapy Is More Effective than Antifungal Treatment in Experimental Cryptococcal Infection

EPEN-04. RECURRENT EPENDYMOMA: ROLE OF INTRAVENTRICULAR TARGETED RADIOIMMUNOTHERAPY

7PCOMBINATION OF CETUXIMAB WITH RADIOIMMUNOTHERAPY SIGNIFICANTLY ENHANCES THERAPEUTIC RESPONSE IN COLORECTAL CANCER

NIMG-42. INCIDENCE OF CAVERNOMATOUS LESIONS ON BRAIN MR OF PEDIATRIC PATIENTS TREATED WITH INTRAVENTRICULAR RADIOIMMUNOTHERAPY

RONC-06. INCIDENCE OF CAVERNOMATOUS LESIONS ON BRAIN MR OF PEDIATRIC PATIENTS TREATED WITH INTRAVENTRICULAR RADIOIMMUNOTHERAPY

IMMU-25. RADIO-IMMUNOTHERAPY USING THE IDO PATHWAY INHIBITOR INDOXIMOD FOR CHILDREN WITH NEWLY-DIAGNOSED DIPG

NSRG-11. DIVERSION OF CSF WITH PROGRAMMABLE VENTRICULOPERITONEAL SHUNTS: ROLE WITH INTRAVENTRICULAR RADIOIMMUNOTHERAPY

EMBR-03. TREATMENT OF EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR) WITH TARGETED RADIOIMMUNOTHERAPY

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?

O-0004FRACTIONATED RADIOIMMUNOTHERAPY WITH 90ϒ-CLIVATUZUMAB TETRAXETAN IN PATIENTS WITH METASTATIC PANCREATIC CANCER AFTER ≥ 2 PRIOR THERAPIES

Interaction of Radiolabeled Antibodies with Fungal Cells and Components of the Immune System In Vitro and during Radioimmunotherapy for Experimental Fungal Infection

PDCT-06. RADIO-IMMUNOTHERAPY USING THE IDO-INHIBITOR INDOXIMOD IN COMBINATION WITH RE-IRRADIATION FOR CHILDREN WITH PROGRESSIVE BRAIN TUMORS IN THE PHASE 1 SETTING: AN UPDATED REPORT OF SAFETY AND TOLERABILITY (NCT02502708)